Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Feasibility Study of the FARAFLEX Mapping and PFA System

NCT: NCT06510556 · RECRUITING

NCT IDNCT06510556
StatusRECRUITING
Start Date2025-02-17
Completion2027-09-15

Brief Summary

The objective of this feasibility study is to evaluate the safety and effectiveness of the FARAFLEX mapping and pulsed field ablation (PFA) catheter, a novel catheter in treating persistent atrial fibrillation (PersAF) or symptomatic Paroxysmal Atrial Fibrillation (PAF).

Frequently Asked Questions

What is Feasibility Study of the FARAFLEX Mapping and PFA System?

Feasibility Study of the FARAFLEX Mapping and PFA System is a clinical trial registered under NCT06510556. Current status: RECRUITING.

What is the status of NCT06510556?

The current status of NCT06510556 (Feasibility Study of the FARAFLEX Mapping and PFA System) is: RECRUITING.

When did Feasibility Study of the FARAFLEX Mapping and PFA System start?

Feasibility Study of the FARAFLEX Mapping and PFA System started on 2025-02-17.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑